SEC Form 4 · accession 0001140361-17-027386
CHEMBIO DIAGNOSTICS, INC. · CEMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gail S Page
Director
Period of report
Jul 4, 2017
Accepted (ET)
Jul 6, 2017 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001092662
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase | $6.05 | Jul 4, 2017 | A | 9,375 | A | Jul 4, 2017 | Jul 1, 2022 | Common Stock | 9,375 | 9,375 | D |
| Option to Purchase | $6.05 | Jul 4, 2017 | A | 9,375 | A | Jul 1, 2018 | Jul 1, 2022 | Common Stock | 9,375 | 9,375 | D |
| Options to Purchase | $6.05 | Jul 4, 2017 | A | 9,375 | A | Jul 1, 2019 | Jul 1, 2022 | Common Stock | 9,375 | 9,375 | D |
| Options to Purchase | $6.05 | Jul 4, 2017 | A | 9,375 | A | Jul 1, 2020 | Jul 1, 2022 | Common Stock | 9,375 | 9,375 | D |
| Options to Purchase | $6.05 | Jul 4, 2017 | A | 9,375 | A | Jul 1, 2021 | Jul 1, 2022 | Common Stock | 9,375 | 9,375 | D |